JAN (NYSE:JAN) Stock Has Average Target Price of $32.31

Posted by Francis Steltz on Oct 31st, 2026

Shares of JAN (NYSE:JAN – Get Free Report) have been assigned an average rating of “Moderate Buy” from the seventeen ratings firms that are presently covering the firm, MarketBeat Ratings reports. Four research analysts have rated the stock with a hold rating, twelve have issued a buy rating and one has given a strong buy rating to the company. The average 12-month price objective among brokers that have issued a report on the stock in the last year is $32.31.

A number of research firms have weighed in on JAN. Royal Bank Of Canada boosted their price objective on shares of JAN from $30.00 to $34.00 and gave the company an “outperform” rating in a research report on Monday, August 10th. Zacks Research cut shares of JAN from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, October 20th. Barclays dropped their price target on shares of JAN from $34.00 to $33.00 and set an “overweight” rating for the company in a research note on Tuesday, October 13th. Jefferies Financial Group assumed coverage on shares of JAN in a report on Tuesday, September 15th. They set a “buy” rating and a $36.00 price target on the stock. Finally, Scotiabank increased their price objective on shares of JAN from $31.00 to $33.00 and gave the stock a “sector outperform” rating in a research report on Thursday, September 17th.

Read Our Latest Stock Report on JAN

More JAN News

Here are the key news stories impacting JAN this week:

Neutral Sentiment: The most recent quarterly update remains the primary fundamental reference: JAN reported revenue of $216.5 million, up 45.4% year over year and above analyst expectations, but earnings per share of $0.05 missed consensus by $0.18.
Neutral Sentiment: Management’s fiscal 2026 EPS guidance remains $0.95–$0.98, broadly in line with the sell-side estimate of $0.97. Investors may continue looking for evidence that earnings can improve after the latest quarterly miss.
Neutral Sentiment: Trading volume was approximately 2.9 million shares, nearly twice the average, suggesting elevated activity despite the lack of a clearly identified JAN-specific catalyst.

JAN Price Performance

NYSE JAN opened at $28.54 on Friday. The business’s 50 day moving average price is $29.68 and its 200-day moving average price is $28.02. JAN has a fifty-two week low of $22.76 and a fifty-two week high of $32.83.

JAN (NYSE:JAN – Get Free Report) last issued its quarterly earnings results on Tuesday, August 4th. The company reported $0.05 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.23 by ($0.18). The company had revenue of $216.46 million during the quarter, compared to the consensus estimate of $203.32 million. The firm’s quarterly revenue was up 45.4% compared to the same quarter last year. JAN has set its FY 2026 guidance at 0.950-0.980 EPS. On average, equities research analysts expect that JAN will post 0.97 earnings per share for the current year.

JAN Dividend Announcement

The firm also recently announced a monthly dividend, which will be paid on Tuesday, December 29th. Shareholders of record on Friday, December 18th will be given a dividend of $0.0475 per share. This represents a $0.57 annualized dividend and a dividend yield of 2.0%. The ex-dividend date is Friday, December 18th.

Institutional Investors Weigh In On JAN

Hedge funds and other institutional investors have recently modified their holdings of the business. Nisa Investment Advisors LLC bought a new position in JAN in the 3rd quarter valued at $27,000. State of Wyoming lifted its position in shares of JAN by 258.7% during the third quarter. State of Wyoming now owns 4,814 shares of the company’s stock worth $143,000 after purchasing an additional 3,472 shares during the last quarter. Inspire Investing LLC bought a new stake in shares of JAN during the third quarter worth $484,000. Greenland Capital Management LP bought a new stake in shares of JAN during the second quarter worth $575,000. Finally, Sumitomo Mitsui DS Asset Management Company Ltd purchased a new stake in shares of JAN during the third quarter valued at $627,000. 6.27% of the stock is currently owned by hedge funds and other institutional investors.

JAN Company Profile

(Get Free Report)

JanOne Inc (NYSE: JAN) is a social-impact and technology company focused on addressing the opioid crisis. Its activities have included the development and commercialization of solutions intended to support opioid-related treatment and prevention, with an emphasis on using business and technology to promote measurable social benefits.

Through its subsidiaries and related operations, JanOne has also pursued financial technology initiatives, including blockchain-based payment and transaction solutions.